Rare Allergy's hidden toll: study aims to quantify suffering

NCT ID NCT07391917

Not yet recruiting Knowledge-focused Sponsor: University Hospital, Angers Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

Human seminal plasma allergy is a rare condition causing pain and inflammation after unprotected sex, but its impact on quality of life is poorly understood. This study will enroll 20 women treated at Angers University Hospital to compare standard quality-of-life questionnaires and a simple rating question. The goal is to describe how this allergy affects physical, mental, and sexual health, and to determine if a disease-specific questionnaire is needed.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this study could show how much this rare allergy affects daily life and sexual health, and support the creation of a dedicated quality-of-life questionnaire.
What could go wrong: This is a small, early-stage observational study with only 20 participants, so results may not apply to everyone. It does not test a treatment, so no direct health benefit is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLERGIC REACTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

allergic disease hypersensitivity reaction disease Sexuality

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLERGIC REACTION

Contacts and locations

Locations

Sandra MERZEAU

Angers, 49933, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.